Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL £65
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house

Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References

(PubMed link indicates BioLegend citation)
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  4. Kim S, et al. 2020. Development. 147:00:00. PubMed
  5. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  6. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  7. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  8. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  9. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  10. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  11. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  12. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  13. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  14. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  15. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  16. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  17. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  18. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  19. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  20. Poli V, et al. 2021. iScience. 24:103256. PubMed
  21. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  22. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  23. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  24. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  25. Stewart CA, et al. 2020. bioRxiv. . PubMed
  26. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  27. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  28. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  29. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  30. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  31. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  32. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  33. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  34. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  35. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  36. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  37. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  38. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  39. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  40. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  41. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  42. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  43. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  44. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  45. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  46. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  47. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  48. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  49. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  50. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  51. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  52. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  53. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  54. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  55. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  56. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  57. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  58. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  59. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  60. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  61. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  62. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  63. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  64. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  65. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  66. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  67. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  68. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  69. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  70. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  71. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  72. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  73. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  74. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  75. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  76. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  77. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  78. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  79. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  80. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  81. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  82. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  83. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  84. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  85. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  86. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  87. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  88. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  89. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  90. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  91. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  92. Kim S, et al. 2020. Development. . PubMed
  93. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  94. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  95. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  96. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  97. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  98. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  99. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  100. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  101. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  102. Ma K, et al. 2022. iScience. 25:104347. PubMed
  103. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  104. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  105. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  106. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  107. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  108. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  109. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  110. Lau H, et al. 2020. Islets. 41:12. PubMed
  111. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  112. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  113. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  114. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  115. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  116. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  117. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  118. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  119. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  120. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  121. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  122. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  123. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  124. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  125. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  126. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  127. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  128. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  129. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  130. Lee G, et al. 2021. Viruses. 13: . PubMed
  131. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  132. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  133. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  134. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  135. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  136. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  137. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  138. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  139. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  140. Su Y, et al. 2020. Cell. 1479:183. PubMed
  141. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  142. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  143. Wang X, et al. 2022. Elife. 11:. PubMed
  144. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  145. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  146. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  147. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  148. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  149. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  150. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  151. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  152. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  153. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  154. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  155. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  156. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  157. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  158. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  159. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  160. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account